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 S-073 
Use of Cell Penetrating Peptides to Treat Inflammatory Responses in Human Uterine Cells. 
Leo RI Gurney,1 Stephen C Robson,1 Arwyn T Jones,2 Michael Taggart.1 1Newcastle 
University, Newcastle Upon Tyne, United Kingdom; 2Cardiff University, Cardiff, United 
Kingdom. 
 
INTRODUCTION: A lack of effective therapies continues to impair attempts to prevent 
preterm birth associated with inflammation. With the aim of broadening the scope of 
candidate agents available to be tested to address this clinical problem we investigated the 
ability of a novel class of peptide vectors, termed Cell Penetrating Peptides (CPPs) attached 
to a peptide cargo, the Nemo Binding Domain (NBD) peptide directed at the inhibition of 
iŶflaŵŵatory NuĐlear FaĐtor Kappa B ;NFκBͿ-related signalling in uterine cells. 
 
METHODS: The ability of three CPP derived vectors (Pen, TAT and R8) to deliver fluorescent 
cargo to human primary myometrial cells was tested using live cell confocal microscopy. 
Western blotting and quantitative polymerase chain reaction gene array techniques 
examined the efficacy of the CPP linked peptide cargo NBD peptide to dampen cytokine 
stimulated inflammatory responses in these cells. 
 
RESULTS: Pen, TAT and R8 were able to deliver fluorescent cargo to uterine myometrial cells 
within one hour over a concentration range of 1-ϭϬμM. The NBD peptide, ĐoŶjugated to PeŶ 
CPP (Pen-NBD), significantly inhibited cytokine stimulated cyclo-oxygenase 2 (COX2) protein 
induction at four hours. 
 
Representative Western blots indicating COX2 protein expression in myometrial cells over a 
four hour time frame following IL1B exposure alone (Control) or with 1 hour pre-incubation 
of increasing concentrations of Pen-NBD. 
 
This effect was not seen with other CPP-NBD conjugations, nor with mutant or un-conjugated 
peptide controls. Data derived from both Western blot and gene array indicated that the anti -
inflammatory effects of Pen-NBD were comparable with a series of non-peptidic small 
ŵoleĐule iŶhiďitors of NFκB. 
 
CONCLUSIONS: This research demonstrates that CPPs can enter human uterine cells and 
deliver cargo to exert an anti-inflammatory effect, opening new avenues for the development 
of treatments aimed at preventing preterm birth associated with inflammation. 
